Christopher M. Crane - Nov 19, 2021 Form 4 Insider Report for EXELON CORP (EXC)

Role
President & CEO
Signature
Elizabeth M. Hensen, Attorney-in-Fact for Christopher M. Crane
Stock symbol
EXC
Transactions as of
Nov 19, 2021
Transactions value $
-$4,069,800
Form type
4
Date filed
11/22/2021, 05:26 PM
Next filing
Jan 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXC Common Stock Options Exercise $11.2M +285K +58.24% $39.21 774K Nov 19, 2021 Direct F1, F3
transaction EXC Common Stock Sale -$15.2M -285K -36.81% $53.49 489K Nov 19, 2021 Direct F1, F2
holding EXC Common Stock 28.5K Nov 19, 2021 Held in trust for benefit of son
holding EXC Common Stock 28.5K Nov 19, 2021 Held in trust for benefit of daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXC NQ Stock Option (right to buy) 04/02/2012 Options Exercise -285K -100% 0 Nov 19, 2021 Common Stock 285K $39.21 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise and sale of shares were made pursuant to a Rule 10b5-1 Trading Plan entered into by Mr. Crane on November 5, 2021.
F2 Shares were sold in multiple lots with prices ranging from $53.22 to $53.79 inclusive. Mr Crane undertakes to provide to Exelon Corporation, any security holder of Exelon Corporation or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at at each separate price within the range provided above.
F3 Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1.